1 – 4 Juillet 2020
ESMO World Congress on Gastrointestinal Cancer, 2020 Virtual
[Abstract P-80] A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)
29 Mai – 2 Juin 2020
American Association of Clinical Oncology (ASCO)
[Abstract TPS4666] Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)
Abstract #4617: ctDNA is prognostic and potentially predictive of eryaspase efficacy in patients with advanced pancreatic adenocarcinoma
10 – 14 Decembre 2019
The San Antonio Breast Cancer Symposium
TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (NCT03674242)
3 – 4 Octobre 2019
CAPACITES DE LA PLATEFORME THERAPEUTIQUE ERYCAPS®
Profil protéomique de globules rouges soumis à un procédé d’encapsulation par dialyse hypotonique
2 – 4 Octobre 2019
DRUG-LOADED ERYTHROCYTES AS A NEW THERAPEUTIC OPTION IN ONCOLOGY
27 Septembre – 1er Octobre 2019
TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (NCT03674242)
6 – 9 Septembre 2019
AACR pancreatic meeting, Boston
TRYbeCA-1: A Randomized, Phase 3 Study of Eryaspase in CombinaBon with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in PaBents with PancreaBc Adenocarcinoma (NCT03665441)
4 Juillet 2019
ESMO World Congress on Gastrointestinal Cancer 2019
Abstract P-098: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)
1er Avril 2019
AACR – American Association for Cancer Research
Erymethionase (methionine-γ-lyase encapsulated into red blood cells)
potentiates anti-PD1 therapy in TNBC-like syngeneic mouse model
11 Mars 2019
ERCS European Red Cell Research Society 22nd Meeting
Profilage protéomique complet des érythrocytes à la suite d’un procédé hypotonique d’encapsulation de médicaments basé sur la dialyse
17-19 Janvier 2019
Gastrointestinal Cancers Symposium (ASCO-GI)
Abstract TPS471: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).
14-17 Juin 2018
European Hematology Association (EHA) Congress
Preclinical Demonstration of Intracellular Activity of Asparaginase Encapsulated in Red Blood Cells Both in the Absence and in the Presence of Neutralizing Anti-Asparaginase Antibodies
Quand : Vendredi 15 Juin 2018 / 17h30 – 19h00
A Phase 2b of Eryaspase in Combination with Low-Dose Cytarabine as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemia (ENFORCE – NCT01810705)
Quand : Samedi 16 Juin 2018 / 17h30 – 19h00
Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Eryaspase (L-Asparaginase Encapsulated in Red Blood Cells)
1-5 Juin 2018
American Society of Cancer Oncology (ASCO)
Pharmacodynamic Characterization of eryaspase (L-asparaginase Encapsulated in Red Blood Cells) in Combination with Chemotherapy in a Phase 2/3 Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517).
Quand : 4 Juin 2018
14-18 avril 2018
American Association for Cancer Research (AACR)
A Phase 1 Study Of Eryaspase (L-Asparaginase Encapsulated In Red Blood Cells) In Combination With Induction And Consolidation Chemotherapy For Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) (NCT01910428)
Quand : 15 avril 2018
Enzymatic combination investigation in cancer therapy
Quand : 18 avril 2018
8-12 septembre 2017
European Society for Medical Oncology (ESMO)
A Phase 2b of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180)
Quand : 8-11 septembre 2017
5-8 septembre 2017
13th International Congress of Inborn Errors of Metabolism (ICIEM)
Eryminase, Arginine Deiminase-Encapsulated in Red Blood Cells Effectively Lower Blood Arginine Levels in a Mouse Model of Inducible Hyperargininemia
Quand : 6 septembre 2017/ 5:30-8:00PM BRT
Erymethionase, Methioninase Entrapped in Red Blood Cells: an innovative treatment approach for classical homocystinuria
Quand : 6 septembre 2017/ 5:30-8:00PM BRT
1-5 avril 2017
American Association for Cancer Research (AACR) Annual Meeting
Use of methionine gamma-lyase-loaded erythrocytes to induce effective methionine depletion of cancer therapy
Quand : 3 avril 2017/1:00-5:00 PM EDT
19-21 janvier 2017
2017 Gastrointestinal Cancers Symposium (ASCO GI)Methionine gamma-lyase-encapsulated into red blood cells (ERY-MET) shows profound antitumor activity in gastric carcinoma